AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$CBLL

Blumberg Scott sold $37K of CBLL

Blumberg Scott (Chief Financial Officer) sold 1,521 shares of Ceribell, Inc. (CBLL) at $24.02 on 2026-08-21.

Original reporting
SEC EDGAR · Blumberg Scott
Published Aug 25, 2026, 11:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 11:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$CBLL
Neutral
high confidence
Mentioned
$CBLL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBLLNeutralLow
01

Why it matters

The CFO's modest sale is unlikely to affect market perception of Ceribell.

02

Market read

Small insider sale with limited trading relevance.

03

What to watch

Potential upcoming earnings or corporate actions not disclosed.

Relevance 3/10Novelty 4/10Timing: filing date 2026-08-25, reflects sale on 2026-08-21

Background

Form 4 filing reports insider transactions; used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$CBLLNeutralHigh confidence
Context

CFO Blumberg Scott sold 1,521 shares for $36,534, a direct insider sale disclosed via Form 4.

Expected impact

No significant price impact expected.

Evidence & confidence

Sale size is small relative to total holdings and market cap; CFO remains a large holder.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Company
    Ceribell, Inc.

    Medical device company listed on NASDAQ under CBLL.

  • Individual
    Blumberg Scott

    Chief Financial Officer of Ceribell.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CBLL insider trading history →

Related articles

AUG 10
$CBLLHigh

Ceribell, Inc. (CBLL): Results of Operations and Financial Condition

Ceribell, Inc. (CBLL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ceribell Reports Second Quarter 2026 Financial Results Sunnyvale, Calif. – August 10, 2026 – CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today repor

SEC EDGAR 8-K6 min